Jacobs Develops New Model to Help Clients Manage Remobilization of Public Operations and Capital Programs
Jacobs has developed a new COVID-19 modeling software program that is based on accepted probabilistic modeling techniques, and fuses publicly available datasets for COVID-19 infection statistics, sources such as the Centers for Disease Control and Prevention isolation guidelines, other publicly available data, and client or organizational-level data, and explores the differences between virus propagation based on various non-pharmaceutical interventions.
View more
Jacobs Awarded Solar Photovoltaic Power Plant Contract in Malaysia
Jacobs was appointed by Hanwha Energy Corporation to deliver owner's engineer services to support the design, engineering, procurement, construction, installation, testing and commissioning of a new 100 megawatt alternating current (MWac) solar photovoltaic power plant in Pekan, Pahang, Malaysia.
View more
Jacobs Strengthens Public Engagement Solutions with New Virtual Event Space
Jacobs is continuing its leadership in public engagement solutions, with the launch of a new, fully customized, online and interactive Jacobs' Virtual Event Space. As part of Jacobs' global suite of digital solutions, the Virtual Event Space can be tailored to deliver deep and meaningful engagement for any client, partner or project.
View more
Jacobs' Designed and Built, Multi-Product Cell Culture (MPCC) Facility Wins International Society for Pharmaceutical Engineering 'Facility of the Year Award'
Jacobs provided architecture, engineering, construction management and turnover services for a world class biopharmaceutical manufacturing facility, Cruiserath Biologics based in Dublin, Ireland, which, has won the Project Execution category at the International Society for Pharmaceutical Engineering (ISPE) 2020 Facility of the Year Awards (FOYA). The award recognizes innovation in facilities serving the regulated healthcare industry. The factory, optimized for rapid product changeover and future use as a multi-product facility, will support Bristol Myers Squibb in meeting growing global demand for its medicines.
View more